What is Exponent Inc's earnings per share (EPS)?

Exponent Inc (EXPO) reported diluted earnings per share of $2.07 for fiscal year 2025. This represents a -1.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Exponent Inc (EXPO) Financials

EXPO

Trailing 12 months to July 3, 2026

Revenue $632.5M +12.8% YoY

Net Income $111.8M +8.7% YoY

EPS (Diluted) $2.23 +12.1% YoY

Free Cash Flow $108.6M -10.2% YoY

Market Cap $3.4B as of Oct 17, 2026

Price / Sales 5.4x on $632.5M revenue, trailing 12 months to July 3, 2026

Price / Earnings 30.6x on $111.8M net income, trailing 12 months to July 3, 2026

Price / Book 11.8x on $288.6M equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 3, 2026 Reported Aug 7, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EXPO SEC filings page.

Exponent Inc (EXPO) reported $632.5M in revenue over the twelve months to Jul 3, 2026, up 12.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EXPO FY2025 2026-10-04

Exponent’s cash-generative model remains productive, but softer margins and payouts exceeding free cash flow are making the balance sheet more leveraged.

Revenue increased 4.2% while operating cash flow declined between FY2024 and FY2025. With free cash flow margin falling from 24.6% to 21.0%, the latest growth appears less cash-efficient rather than purely volume-driven.

Operating margin eased from 21.4% in FY2024 to 20.6% in FY2025, showing modest operating pressure. Net margin fell to 18.2%, so that pressure reached the bottom line rather than staying confined to operating costs.

Capital returns exceeded internally generated cash: buybacks and dividends totaled $158.7M in FY2025 versus free cash flow of $122.3M. Debt-to-equity rose from 0.85x to 1.0x; the current ratio remained above 2x, indicating short-term coverage while the capital structure became more liability-heavy.

Financial Health Signals

Financial Health Score 70/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Exponent Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Exponent Inc has an operating margin of 20.6%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is down from 21.4% the prior year.

Growth

Exponent Inc's revenue grew a modest 4.2% year-over-year to $582.0M. This slow but positive growth earns a score of 46/100.

Leverage

Exponent Inc has a moderate D/E ratio of 0.99. This balance of debt and equity financing earns a leverage score of 47/100.

Liquidity

With a current ratio of 2.40, Exponent Inc holds $2.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 68/100.

Cash Flow

Exponent Inc converts 21.0% of revenue into free cash flow ($122.3M). This strong cash generation earns a score of 88/100.

Returns

Exponent Inc earns a strong 27.2% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is up from 25.9% the prior year.

Altman Z-Score Safe

8.14

Exponent Inc scores 8.14, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.4B) relative to total liabilities ($387.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/7

Exponent Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.24x

For every $1 of reported earnings, Exponent Inc generates $1.24 in operating cash flow ($131.7M OCF vs $106.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$171.6M

YoY+20.9%

QoQ+3.2%

5Y CAGR+7.4%

10Y CAGR+8.3%

Exponent Inc generated $171.6M in revenue in Q2 2027. This represents an increase of 20.9% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.

EBITDA

$30.7M

YoY+55.9%

QoQ-30.1%

5Y CAGR-0.2%

10Y CAGR+6.4%

Exponent Inc's EBITDA was $30.7M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 55.9% from the same quarter a year earlier. Against the prior quarter it is down 30.1%.

Net Income

$29.4M

YoY+10.7%

QoQ-0.6%

5Y CAGR+3.0%

10Y CAGR+10.9%

Exponent Inc reported $29.4M in net income in Q2 2027. This represents an increase of 10.7% from the same quarter a year earlier. Against the prior quarter it is down 0.6%.

EPS (Diluted)

$0.60

YoY+15.4%

QoQ+1.7%

5Y CAGR+4.6%

10Y CAGR+4.7%

Exponent Inc earned $0.60 per diluted share (EPS) in Q2 2027. This represents an increase of 15.4% from the same quarter a year earlier. Against the prior quarter it is up 1.7%.

Cash & Balance Sheet

Free Cash Flow

$29.1M

YoY-14.2%

QoQ+949.3%

5Y CAGR-7.3%

10Y CAGR+9.0%

Exponent Inc generated $29.1M in free cash flow in Q2 2027, representing cash available after capex. This represents a decrease of 14.2% from the same quarter a year earlier. Against the prior quarter it is up 949.3%.

Cash & Debt

$66.6M

YoY-71.3%

QoQ-43.8%

5Y CAGR-22.6%

10Y CAGR-5.2%

Exponent Inc held $66.6M in cash as of Q2 2027; long-term debt is not reported for that period.

Dividends Per Share

$0.31

YoY+3.3%

QoQ0.0%

5Y CAGR+9.2%

10Y CAGR+5.6%

Exponent Inc paid $0.31 per share in dividends in Q2 2027. This represents an increase of 3.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

48M

YoY-5.9%

QoQ-2.0%

5Y CAGR-1.8%

10Y CAGR+6.2%

Exponent Inc had 48M shares outstanding in Q2 2027. This represents a decrease of 5.9% from the same quarter a year earlier. Against the prior quarter it is down 2.0%.

Margins & Returns

Operating Margin

16.3%

YoY+4.2pp

QoQ-8.5pp

5Y change-8.2pp

10Y change-3.0pp

Exponent Inc's operating margin was 16.3% in Q2 2027, reflecting core business profitability. This is up 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.5 percentage points.

Net Margin

17.1%

YoY-1.6pp

QoQ-0.7pp

5Y change-4.1pp

10Y change+3.6pp

Exponent Inc's net profit margin was 17.1% in Q2 2027, showing the share of revenue converted to profit. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Return on Equity

10.2%

YoY+4.0pp

QoQ+1.4pp

5Y change+3.6pp

10Y change+6.4pp

Exponent Inc's ROE was 10.2% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Gross Margin

Not reported for Q2 2027.

Capital Allocation

Share Buybacks

$67.4M

QoQ-14.5%

Exponent Inc spent $67.4M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 14.5%.

Capital Expenditures

$1.8M

YoY-21.9%

QoQ-27.6%

5Y CAGR+0.5%

10Y CAGR-0.7%

Exponent Inc invested $1.8M in capex in Q2 2027, funding long-term assets and infrastructure. This represents a decrease of 21.9% from the same quarter a year earlier. Against the prior quarter it is down 27.6%.

R&D Spending

Not reported for Q2 2027.

EXPO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EXPO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$632.5M	$582.0M+4.2%	$558.5M+4.1%	$536.8M+4.6%	$513.3M+10.1%	$466.3M+16.6%	$399.9M-4.1%	$417.2M+9.9%	$379.5M+9.1%	$347.8M+10.4%	$315.1M+0.7%	$312.8M+2.7%	$304.7M+2.9%	$296.2M+1.2%	$292.7M+7.4%	$272.4M
SG&A Expenses	$28.0M	$25.5M+12.3%	$22.7M-7.0%	$24.4M+3.3%	$23.7M+54.8%	$15.3M+18.6%	$12.9M-37.2%	$20.5M+17.0%	$17.5M-1.4%	$17.8M+14.8%	$15.5M+1.3%	$15.3M-3.5%	$15.8M+7.7%	$14.7M+8.5%	$13.6M+3.4%	$13.1M
Operating Income	$127.6M	$119.8M+0.2%	$119.6M+7.4%	$111.3M-21.0%	$140.8M+29.3%	$108.9M+30.8%	$83.2M-2.2%	$85.1M-6.9%	$91.5M+26.9%	$72.1M+16.4%	$61.9M-10.2%	$68.9M+8.5%	$63.5M+13.6%	$55.9M-2.9%	$57.6M+7.8%	$53.5M
EBITDA	N/A	$129.9M+0.5%	$129.2M+7.5%	$120.2M-18.7%	$147.9M+28.2%	$115.4M+28.1%	$90.1M-2.0%	$91.9M-6.0%	$97.7M+24.8%	$78.3M+15.1%	$68.0M-8.6%	$74.4M+7.9%	$69.0M+13.2%	$60.9M-2.3%	$62.3M+7.7%	$57.9M
Income Tax	$44.1M	$41.3M+7.6%	$38.4M+7.9%	$35.6M+18.9%	$29.9M+21.4%	$24.6M+71.3%	$14.4M-33.8%	$21.7M+3.2%	$21.1M-48.9%	$41.2M+90.4%	$21.6M-21.4%	$27.5M+1.0%	$27.3M+7.7%	$25.3M+3.2%	$24.5M+10.8%	$22.1M
Net Income	$111.8M	$106.0M-2.7%	$109.0M+8.6%	$100.3M-1.9%	$102.3M+1.1%	$101.2M+22.6%	$82.6M+0.1%	$82.5M+14.1%	$72.3M+74.9%	$41.3M-13.0%	$47.5M+8.9%	$43.6M+7.1%	$40.7M+5.3%	$38.6M+3.8%	$37.2M+13.9%	$32.7M
EPS (Basic)	N/A	$2.08-2.3%	$2.13+8.7%	$1.96-1.0%	$1.98+3.1%	$1.92+21.5%	$1.58+1.3%	$1.56+13.9%	$1.37+75.6%	$0.78-13.3%	$0.90-45.1%	$1.64+8.6%	$1.51+6.3%	$1.42-47.4%	$2.70+16.9%	$2.31
EPS (Diluted)	$2.23	$2.07-1.9%	$2.11+8.8%	$1.94-1.0%	$1.96+3.2%	$1.90+22.6%	$1.55+1.3%	$1.53+15.0%	$1.33	$0.77-11.5%	$0.87	$1.60	$1.47+6.5%	$1.38	$2.60+17.1%	$2.22
Diluted Shares (Avg)	N/A	51M-0.6%	52M-0.1%	52M-1.2%	52M-2.0%	53M0.0%	53M-1.0%	54M-0.5%	54M	54M-0.7%	54M	27M	28M-1.4%	28M	14M-3.1%	15M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Revenue	$171.6M+20.9%	$166.3M+14.3%	$147.4M+7.8%	$147.1M+8.0%	$142.0M+1.0%	$145.5M+0.4%	$136.8M+11.3%	$136.3M+2.2%
SG&A Expenses	$7.4M+20.5%	$6.2M+23.9%	$6.7M+16.9%	$7.7M+44.2%	$6.1M+1.8%	$5.0M-11.2%	$5.7M-3.4%	$5.3M-11.8%
Operating Income	$28.0M+63.1%	$41.4M-6.9%	$29.1M+6.9%	$29.0M+12.3%	$17.2M-51.9%	$44.4M+44.7%	$27.3M+48.2%	$25.8M-23.8%
EBITDA	$30.7M+55.9%	$43.9M-6.5%	$31.7M+6.5%	$31.6M+11.8%	$19.7M-48.5%	$46.9M+42.0%	$29.7M+43.2%	$28.2M-22.2%
Income Tax	$11.4M+10.8%	$12.8M+14.9%	$9.3M+20.7%	$10.6M+6.9%	$10.3M-1.8%	$11.1M+8.1%	$7.7M-15.5%	$9.9M+4.4%
Net Income	$29.4M+10.7%	$29.6M+11.0%	$24.8M+5.0%	$28.0M+7.7%	$26.6M-9.1%	$26.6M-11.6%	$23.6M+12.7%	$26.0M+6.1%
EPS (Basic)	$0.60+15.4%	$0.59+13.5%	$0.49+6.5%	$0.55+7.8%	$0.52-8.8%	$0.52-11.9%	$0.46+12.2%	$0.51+6.3%
EPS (Diluted)	$0.60+15.4%	$0.59+13.5%	$0.49+8.9%	$0.55+10.0%	$0.52-8.8%	$0.52-11.9%	$0.45+12.5%	$0.50+4.2%
Diluted Shares (Avg)	49M-4.9%	50M-3.0%	N/A	51M-0.9%	52M0.0%	52M+0.4%	N/A	52M0.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense.

EXPO Balance Sheet

EXPO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$777.5M0.0%	$777.3M+20.2%	$646.8M+10.2%	$586.7M-14.2%	$683.7M+17.9%	$580.1M+3.0%	$563.4M+20.1%	$468.9M+6.7%	$439.6M+8.9%	$403.7M+4.2%	$387.5M+6.1%	$365.3M+6.1%	$344.2M+9.1%	$315.4M+17.3%	$268.8M
Current Assets	$427.6M-4.3%	$446.9M+17.7%	$379.5M+8.7%	$349.2M-22.9%	$452.8M+23.4%	$366.8M+0.8%	$364.0M+11.5%	$326.6M+3.5%	$315.5M+15.1%	$274.0M+0.5%	$272.8M+6.8%	$255.5M+1.5%	$251.7M+6.9%	$235.4M+18.6%	$198.6M
Cash & Equivalents	$221.9M-14.3%	$258.9M+38.3%	$187.2M+15.9%	$161.5M-45.8%	$297.7M+50.7%	$197.5M+12.0%	$176.4M+38.9%	$127.1M+1.8%	$124.8M+8.5%	$115.0M-8.6%	$125.8M-2.9%	$129.5M+5.3%	$122.9M+8.5%	$113.3M+34.1%	$84.4M
Short-Term Investments	$0	$0	$0	$0	$0-100.0%	$45.0M-18.4%	$55.2M-32.3%	$81.5M+13.8%	$71.6M+21.9%	$58.8M+28.2%	$45.8M+84.0%	$24.9M-24.9%	$33.2M+58.9%	$20.9M-17.3%	$25.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$374K-49.4%	$739K
Accounts Receivable	$181.5M+12.5%	$161.4M-3.6%	$167.4M-1.6%	$170.1M+21.6%	$139.9M+25.4%	$111.6M-7.1%	$120.1M+13.5%	$105.8M-3.9%	$110.1M+26.0%	$87.4M-1.3%	$88.6M+2.6%	$86.4M+12.2%	$77.0M-9.8%	$85.4M+16.8%	$73.1M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M
Total Liabilities	$387.2M+8.7%	$356.2M+22.5%	$290.7M+9.3%	$265.9M-0.3%	$266.7M+22.0%	$218.6M+2.6%	$213.2M+37.5%	$155.0M+3.0%	$150.5M+15.4%	$130.4M+4.6%	$124.7M+3.1%	$121.0M+10.9%	$109.1M+10.2%	$99.0M+20.6%	$82.1M
Current Liabilities	$178.0M+9.1%	$163.2M+0.8%	$161.9M+1.8%	$159.0M+4.0%	$153.0M+30.4%	$117.3M-5.4%	$124.0M+26.1%	$98.3M+5.6%	$93.1M+16.0%	$80.2M-0.3%	$80.5M+1.4%	$79.3M+10.0%	$72.1M+0.5%	$71.8M+18.1%	$60.8M
Non-Current Liabilities	$209.2M+8.4%	$193.0M+49.9%	$128.8M+20.5%	$106.9M-6.0%	$113.7M+12.2%	$101.3M+13.6%	$89.2M+57.3%	$56.7M-1.2%	$57.4M+14.4%	$50.2M+13.4%	$44.2M+6.2%	$41.7M+12.7%	$37.0M+35.8%	$27.2M+27.8%	$21.3M
Total Equity	$390.3M-7.3%	$421.1M+18.2%	$356.1M+11.0%	$320.8M-23.1%	$417.1M+15.4%	$361.5M+3.2%	$350.3M+11.6%	$313.9M+8.6%	$289.1M+5.8%	$273.3M+4.0%	$262.8M+7.6%	$244.3M+3.9%	$235.1M+8.6%	$216.4M+15.9%	$186.7M
Retained Earnings	$668.4M+7.1%	$624.2M+8.7%	$574.1M+8.6%	$528.8M+10.5%	$478.4M+13.4%	$421.8M+9.7%	$384.7M+12.5%	$342.0M+12.5%	$304.0M+4.4%	$291.2M+8.2%	$269.3M+9.0%	$247.0M+9.3%	$226.0M+9.7%	$206.1M+14.8%	$179.4M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Total Assets	$652.7M-14.1%	$687.4M-9.9%	$777.5M0.0%	$761.4M+2.3%	$759.4M+7.1%	$763.2M+21.3%	$777.3M+20.2%	$744.1M+23.5%
Current Assets	$312.0M-26.7%	$340.9M-21.2%	$427.6M-4.3%	$416.8M+1.0%	$425.7M+8.8%	$432.8M+22.8%	$446.9M+17.7%	$412.6M+20.2%
Cash & Equivalents	$66.6M-71.3%	$118.6M-51.6%	$221.9M-14.3%	$207.4M-5.6%	$231.8M+14.0%	$245.1M+45.3%	$258.9M+38.3%	$219.7M+60.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$218.5M+27.8%	$197.3M+18.3%	$181.5M+12.5%	$182.0M+7.9%	$171.0M+3.1%	$166.8M+2.4%	$161.4M-3.6%	$168.6M-7.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%	$8.6M0.0%
Total Liabilities	$364.1M+9.8%	$349.0M+8.5%	$387.2M+8.7%	$358.6M+7.4%	$331.7M+5.0%	$321.8M+26.2%	$356.2M+22.5%	$333.8M+34.1%
Current Liabilities	$157.8M+16.9%	$142.2M+9.2%	$178.0M+9.1%	$154.8M+12.4%	$135.0M+2.4%	$130.3M+14.1%	$163.2M+0.8%	$137.7M+6.2%
Non-Current Liabilities	$206.3M+4.9%	$206.8M+8.0%	$209.2M+8.4%	$203.8M+4.0%	$196.7M+6.8%	$191.6M+35.9%	$193.0M+49.9%	$196.1M+64.5%
Total Equity	$288.6M-32.5%	$338.3M-23.4%	$390.3M-7.3%	$402.9M-1.8%	$427.8M+8.8%	$441.4M+17.9%	$421.1M+18.2%	$410.3M+16.0%
Retained Earnings	$696.4M+7.8%	$682.0M+7.4%	$668.4M+7.1%	$658.8M+7.1%	$646.0M+7.1%	$635.0M+7.9%	$624.2M+8.7%	$615.0M+8.6%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

EXPO Cash Flow Statement

EXPO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$118.1M	$131.7M-8.9%	$144.5M+13.5%	$127.4M+35.8%	$93.8M-24.7%	$124.6M+20.6%	$103.3M-4.4%	$108.1M+18.5%	$91.2M+34.4%	$67.8M+1.3%	$66.9M+10.7%	$60.5M+25.4%	$48.3M-21.9%	$61.8M+27.4%	$48.5M+4.1%	$46.6M
Depreciation & Amortization	N/A	$10.1M+4.1%	$9.7M+8.7%	$8.9M+25.9%	$7.1M+9.1%	$6.5M-5.6%	$6.9M+1.0%	$6.8M+8.2%	$6.3M+0.1%	$6.3M+2.5%	$6.1M+11.9%	$5.5M+1.4%	$5.4M+9.1%	$5.0M+5.1%	$4.7M+6.8%	$4.4M
Stock-Based Compensation	N/A	$23.8M+2.4%	$23.2M+14.2%	$20.4M0.0%	$20.4M+5.7%	$19.3M+11.5%	$17.3M-1.1%	$17.5M+2.8%	$17.0M+5.2%	$16.2M+21.2%	$13.3M+2.9%	$13.0M-0.9%	$13.1M-0.7%	$13.2M+6.4%	$12.4M+19.7%	$10.3M
Capital Expenditures	$9.6M	$9.4M+35.3%	$6.9M-57.6%	$16.4M+35.8%	$12.0M+76.4%	$6.8M+36.9%	$5.0M-78.4%	$23.0M+41.4%	$16.3M+244.9%	$4.7M-67.2%	$14.4M+167.6%	$5.4M+8.7%	$4.9M-20.5%	$6.2M+26.0%	$4.9M+28.9%	$3.8M
Free Cash Flow	$108.6M	$122.3M-11.1%	$137.6M+24.0%	$111.0M+35.8%	$81.8M-30.6%	$117.7M+19.7%	$98.3M+15.6%	$85.0M+13.5%	$74.9M+18.7%	$63.1M+20.1%	$52.6M-4.6%	$55.1M+27.3%	$43.3M-22.1%	$55.6M+27.6%	$43.6M+1.9%	$42.8M
Investing Cash Flow	-$9.6M	-$9.4M-35.3%	-$6.9M+57.6%	-$16.4M-35.8%	-$12.0M-131.5%	$38.2M+659.9%	$5.0M+17.7%	$4.3M+116.5%	-$25.8M-45.7%	-$17.7M+35.4%	-$27.4M-1.5%	-$27.0M	N/A	N/A	-$1.2M+96.0%	-$29.4M
Financing Cash Flow	-$273.7M	-$160.4M-146.4%	-$65.1M+24.3%	-$86.0M+60.2%	-$216.0M-244.2%	-$62.8M+29.0%	-$88.4M-39.3%	-$63.4M-1.5%	-$62.5M-51.5%	-$41.3M+16.1%	-$49.2M-33.2%	-$36.9M	N/A	N/A	-$18.9M+52.1%	-$39.3M
Dividends Paid	$61.5M	$61.5M+5.7%	$58.2M+7.7%	$54.0M+9.8%	$49.2M+14.0%	$43.2M+8.6%	$39.8M+18.7%	$33.5M+23.1%	$27.2M+24.7%	$21.8M+16.3%	$18.8M+20.0%	$15.6M+19.8%	$13.1M+64.7%	$7.9M	$0	$0
Share Buybacks	$210.6M	$97.1M+1600.4%	$5.7M-76.4%	$24.2M-84.5%	$155.9M+2126.5%	$7.0M-82.5%	$40.0M+82.4%	$22.0M-21.3%	$27.9M+134.0%	$11.9M-51.2%	$24.5M+4.9%	$23.3M-24.6%	$30.9M+21.2%	$25.5M+11.5%	$22.9M-43.6%	$40.6M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Operating Cash Flow	$30.9M-14.7%	-$975K-113.4%	$55.6M-0.8%	$32.7M+9.9%	$36.2M-25.1%	$7.3M-30.3%	$56.1M-21.4%	$29.7M+33.8%
Depreciation & Amortization	$2.7M+6.3%	$2.5M+0.9%	$2.5M+2.0%	$2.5M+6.0%	$2.5M+1.4%	$2.5M+7.2%	$2.5M+4.6%	$2.4M+1.2%
Stock-Based Compensation	N/A	$9.1M+10.7%	N/A	N/A	N/A	$8.2M+11.4%	N/A	N/A
Capital Expenditures	$1.8M-21.9%	$2.5M+39.9%	$2.7M+3.5%	$2.7M+56.1%	$2.3M+98.4%	$1.8M+18.4%	$2.6M+34.3%	$1.7M-48.2%
Free Cash Flow	$29.1M-14.2%	-$3.4M-162.1%	$52.9M-1.0%	$30.0M+7.1%	$33.9M-28.1%	$5.5M-38.3%	$53.5M-22.9%	$28.0M+48.2%
Investing Cash Flow	-$1.8M+21.9%	-$2.5M-39.9%	-$2.7M-3.5%	-$2.7M-56.1%	-$2.3M-98.4%	-$1.8M-18.4%	-$2.6M-34.3%	-$1.7M+48.2%
Financing Cash Flow	-$81.2M-71.0%	-$99.7M-397.2%	-$38.4M-211.7%	-$54.5M-320.6%	-$47.5M-276.7%	-$20.0M+26.4%	-$12.3M+38.5%	-$13.0M+56.2%
Dividends Paid	$15.0M-1.4%	$16.6M+1.3%	$14.9M+4.6%	$15.1M+6.0%	$15.2M+7.2%	$16.4M+5.0%	$14.2M+8.2%	$14.2M+7.9%
Share Buybacks	$67.4M	$78.8M	$24.4M+2438200.0%	$40.0M+4003100.0%	N/A	N/A	$1K-100.0%	-$1K

EXPO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EXPO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	20.6%-0.8pp	21.4%+0.7pp	20.7%-6.7pp	27.4%+4.1pp	23.4%+2.5pp	20.8%+0.4pp	20.4%-3.7pp	24.1%+3.4pp	20.7%+1.1pp	19.7%-2.4pp	22.0%+1.2pp	20.9%+2.0pp	18.9%-0.8pp	19.7%+0.1pp	19.6%
Net Margin	18.2%-1.3pp	19.5%+0.8pp	18.7%-1.2pp	19.9%-1.8pp	21.7%+1.1pp	20.6%+0.9pp	19.8%+0.7pp	19.0%+7.2pp	11.9%-3.2pp	15.1%+1.1pp	13.9%+0.6pp	13.4%+0.3pp	13.1%+0.3pp	12.7%+0.7pp	12.0%
Return on Equity	27.2%+1.3pp	25.9%-2.3pp	28.2%-3.7pp	31.9%+7.6pp	24.3%+1.4pp	22.8%-0.7pp	23.5%+0.5pp	23.0%+8.7pp	14.3%-3.1pp	17.4%+0.8pp	16.6%-0.1pp	16.7%+0.2pp	16.4%-0.8pp	17.2%-0.3pp	17.5%
Return on Assets	13.6%-0.4pp	14.0%-1.5pp	15.5%-1.9pp	17.4%+2.6pp	14.8%+0.6pp	14.2%-0.4pp	14.6%-0.8pp	15.4%+6.0pp	9.4%-2.4pp	11.8%+0.5pp	11.3%+0.1pp	11.1%-0.1pp	11.2%-0.6pp	11.8%-0.4pp	12.2%
Current Ratio	2.40-0.3x	2.74+0.4x	2.34+0.1x	2.20-0.8x	2.96-0.2x	3.13+0.2x	2.94-0.4x	3.32-0.1x	3.390.0x	3.420.0x	3.39+0.2x	3.22-0.3x	3.49+0.2x	3.280.0x	3.27
Debt-to-Equity	0.99+0.1x	0.850.0x	0.820.0x	0.83+0.2x	0.640.0x	0.600.0x	0.61+0.1x	0.490.0x	0.520.0x	0.480.0x	0.470.0x	0.500.0x	0.460.0x	0.460.0x	0.44
Asset Turnover	0.750.0x	0.72-0.1x	0.830.0x	0.87+0.2x	0.680.0x	0.69-0.1x	0.74-0.1x	0.810.0x	0.790.0x	0.780.0x	0.810.0x	0.830.0x	0.86-0.1x	0.93-0.1x	1.01
FCF Margin	21.0%-3.6pp	24.6%+4.0pp	20.7%+4.8pp	15.9%-9.3pp	25.3%+0.7pp	24.6%+4.2pp	20.4%+0.7pp	19.7%+1.6pp	18.1%+1.5pp	16.7%-0.9pp	17.6%+3.4pp	14.2%-4.5pp	18.8%+3.9pp	14.9%-0.8pp	15.7%

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Operating Margin	16.3%+4.2pp	24.9%-5.7pp	19.8%-0.2pp	19.7%+0.8pp	12.1%-13.3pp	30.5%+9.3pp	19.9%+5.0pp	19.0%-6.5pp
Net Margin	17.1%-1.6pp	17.8%-0.5pp	16.8%-0.4pp	19.1%-0.1pp	18.7%-2.1pp	18.3%-2.5pp	17.3%+0.2pp	19.1%+0.7pp
Return on Equity	10.2%+4.0pp	8.7%+2.7pp	6.3%+0.7pp	7.0%+0.6pp	6.2%-1.2pp	6.0%-2.0pp	5.6%-0.3pp	6.3%-0.6pp
Return on Assets	4.5%+1.0pp	4.3%+0.8pp	3.2%+0.2pp	3.7%+0.2pp	3.5%-0.6pp	3.5%-1.3pp	3.0%-0.2pp	3.5%-0.6pp
Current Ratio	1.98-1.2x	2.40-0.9x	2.40-0.3x	2.69-0.3x	3.15+0.2x	3.32+0.2x	2.74+0.4x	3.00+0.3x
Debt-to-Equity	1.26+0.5x	1.03+0.3x	0.99+0.1x	0.89+0.1x	0.780.0x	0.730.0x	0.850.0x	0.81+0.1x
Asset Turnover	0.26+0.1x	0.24+0.1x	0.190.0x	0.190.0x	0.190.0x	0.190.0x	0.180.0x	0.180.0x
FCF Margin	17.0%-6.9pp	-2.1%-5.9pp	35.9%-3.2pp	20.4%-0.2pp	23.9%-9.7pp	3.8%-2.4pp	39.1%-17.4pp	20.5%+6.4pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Exponent Inc EXPO	FY2025	$582.0M	$106.0M	18.2%	$3.4B	70/100
Tutor Perini Corporation TPC	FY2025	$5.5B	$80.4M	1.5%	$4.1B	55/100
Argan, Inc AGX	FY2026	$944.6M	$137.8M	14.6%	$4.8B	70/100
Everus Construction Group, Inc. ECG	FY2025	$3.7B	$201.8M	5.4%	$5.6B	66/100
MYR Group, Inc. MYRG	FY2025	$3.7B	$118.4M	3.2%	$4.4B	54/100
Arcosa, Inc. ACA	FY2025	$2.9B	$208.4M	7.2%	$7.2B	57/100

Where Exponent Inc Ranks

Frequently Asked Questions

What is Exponent Inc's annual revenue?

Exponent Inc (EXPO) reported $582.0M in total revenue for fiscal year 2025. This represents a 4.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Exponent Inc's revenue growing?

Exponent Inc (EXPO) revenue grew by 4.2% year-over-year, from $558.5M to $582.0M in fiscal year 2025.

Is Exponent Inc profitable?

Yes, Exponent Inc (EXPO) reported a net income of $106.0M in fiscal year 2025, with a net profit margin of 18.2%.

What is Exponent Inc's EBITDA?

Exponent Inc (EXPO) had EBITDA of $129.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Exponent Inc's operating margin?

Exponent Inc (EXPO) had an operating margin of 20.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Exponent Inc's net profit margin?

Exponent Inc (EXPO) had a net profit margin of 18.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Exponent Inc pay dividends?

Yes, Exponent Inc (EXPO) paid $1.20 per share in dividends during fiscal year 2025.

What is Exponent Inc's return on equity (ROE)?

Exponent Inc (EXPO) has a return on equity of 27.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Exponent Inc's free cash flow?

Exponent Inc (EXPO) generated $122.3M in free cash flow during fiscal year 2025. This represents a -11.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Exponent Inc's operating cash flow?

Exponent Inc (EXPO) generated $131.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Exponent Inc's total assets?

Exponent Inc (EXPO) had $777.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Exponent Inc's capital expenditures?

Exponent Inc (EXPO) invested $9.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Exponent Inc buy back shares?

Yes, Exponent Inc (EXPO) spent $97.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Exponent Inc have outstanding?

Exponent Inc (EXPO) had 49M shares outstanding as of fiscal year 2025.

What is Exponent Inc's current ratio?

Exponent Inc (EXPO) had a current ratio of 2.40 as of fiscal year 2025, which is generally considered healthy.

What is Exponent Inc's debt-to-equity ratio?

Exponent Inc (EXPO) had a debt-to-equity ratio of 0.99 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Exponent Inc's return on assets (ROA)?

Exponent Inc (EXPO) had a return on assets of 13.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Exponent Inc's P/E ratio?

Exponent Inc (EXPO) trades at 30.6x earnings, its market capitalization divided by net income of $111.8M net income, trailing 12 months to July 3, 2026. The market capitalization is $3.4B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Exponent Inc's price-to-sales ratio?

Exponent Inc (EXPO) trades at 5.4x sales, its market capitalization divided by revenue of $632.5M revenue, trailing 12 months to July 3, 2026. The market capitalization is $3.4B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Exponent Inc's Altman Z-Score?

Exponent Inc (EXPO) has an Altman Z-Score of 8.14, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Exponent Inc's Piotroski F-Score?

Exponent Inc (EXPO) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Exponent Inc's earnings high quality?

Exponent Inc (EXPO) has an earnings quality ratio of 1.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Exponent Inc?

Exponent Inc (EXPO) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.